239 related articles for article (PubMed ID: 434151)
1. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
Geokas MC; Largman C; Brodrick JW; Johnson JH
Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
[TBL] [Abstract][Full Text] [Related]
2. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of human pancreatic anionic trypsinogen in normal serum by radioimmunoassay.
Largman C; Brodrick JW; Geokas MC; Johnson JH
Biochim Biophys Acta; 1978 Nov; 543(4):450-4. PubMed ID: 718983
[TBL] [Abstract][Full Text] [Related]
4. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
Borgström A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
[TBL] [Abstract][Full Text] [Related]
6. A method for determination of immunoreactive trypsin in complex with alpha 1-antitrypsin in human sera.
Borgström A; Ohlsson K
Scand J Clin Lab Invest; 1984 Sep; 44(5):381-6. PubMed ID: 6333064
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic elastase in human serum. Determination by radioimmunoassay.
Geokas MC; Brodrick JW; Johnson JH; Largman C
J Biol Chem; 1977 Jan; 252(1):61-7. PubMed ID: 833129
[TBL] [Abstract][Full Text] [Related]
8. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactive anionic and cationic trypsin in human serum.
Kimland M; Russick C; Marks WH; Borgström A
Clin Chim Acta; 1989 Sep; 184(1):31-46. PubMed ID: 2598466
[TBL] [Abstract][Full Text] [Related]
10. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
Weizman Z
Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
[TBL] [Abstract][Full Text] [Related]
11. Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis.
Durie PR; Gaskin KJ; Geokas MC; O'Rourke M; Largman C
J Pediatr Gastroenterol Nutr; 1982; 1(3):337-43. PubMed ID: 7186046
[TBL] [Abstract][Full Text] [Related]
12. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
Rinderknecht H; Renner IG; Abramson SB; Carmack C
Gastroenterology; 1984 Apr; 86(4):681-92. PubMed ID: 6698368
[TBL] [Abstract][Full Text] [Related]
13. Immunoenzymometric determination of trypsin/alpha 1-protease inhibitor complex in plasma of rats with experimental pancreatitis.
Fletcher TS; Tsukamoto H; Largman C
Clin Chem; 1986 Sep; 32(9):1738-41. PubMed ID: 3527480
[TBL] [Abstract][Full Text] [Related]
14. Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
Carrère J; Chazalette JP; Figarella C
Biochim Biophys Acta; 1989 Dec; 993(2-3):137-42. PubMed ID: 2480820
[TBL] [Abstract][Full Text] [Related]
15. A specific immunoradiometric assay of cationic trypsin(ogen) that does not recognize trypsin-alpha-1-proteinase inhibitor complex.
Lafont P; Guy-Crotte O; Paulin C; Galvain D; Mertani S; Figarella C; Barbier Y
Clin Chim Acta; 1995 Mar; 235(2):197-206. PubMed ID: 7554274
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis.
Geokas MC; Largman C; Durie PR; Brodrick JW; Ray SB; O'Rourke M; Vollmer J
Am J Pathol; 1981 Oct; 105(1):31-9. PubMed ID: 6170231
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of circulating immunoreactive pancreatic anionic trypsinogen in cystic fibrosis: an assay artifact due to cross-reacting serum antibodies.
Moore DJ; Largman C; Kopelman HR; Wong S; Durie PR
Clin Biochem; 1986 Oct; 19(5):303-7. PubMed ID: 3769196
[TBL] [Abstract][Full Text] [Related]
19. Time course profile of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin in patients with acute pancreatitis.
Kemppainen E; Hietaranta A; Puolakkainen P; Hedström J; Haapiainen R; Stenman UH
Scand J Gastroenterol; 2000 Nov; 35(11):1216-20. PubMed ID: 11145296
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of trypsinogen and trypsin in acute and chronic pancreatitis.
Aho HJ; Putzke HP; Nevalainen TJ; Löbel D; Pelliniemi LJ; Dummler W; Suonpää AK; Tessenow W
Digestion; 1983; 27(1):21-8. PubMed ID: 6350076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
